Remove topics patent-assertion-entities
article thumbnail

Back to Life (Sciences) in Amsterdam. A conference report

The IPKat

On 14-16 March, this GuestKat had the opportunity to attend the "Pharma & Biotech Patent Litigation" conference in Amsterdam, which, as many readers will know, not only hosts the Kattenkabinet museum (here below a sample of the oeuvres of the museum.), The IPKat reports on some of the trends and topics from the conference below.

article thumbnail

The Basics of TTAB Oppositions

Fish & Richardson Trademark & Copyright Thoughts

Another person or entity has applied for a trademark at the United States Patent and Trademark Office (the “USPTO”) that is similar to your trademark. Even if you have not registered your trademark, you may be able to assert common law trademark rights in an opposition proceeding. What can you do? Specialized Judges.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

IP Rights, Access, and WHO’s Pandemic Accord

SpicyIP

However, during discussions, these two topics have been the main points of disagreement. Additionally, it encourages patent holders to temporarily waive or manage, as appropriate, payment royalties made by developing country manufacturers. Third parties would accordingly require access to both patents and associated trade secrets.

IP 59
article thumbnail

Optis v Apple Trial E (Part I): findings on specific issues and topics

The IPKat

Findings on specific issues and topics Data regarding the stack Data regarding the stack could not be obtained directly from ETSI. Their conclusions were enormously unreliable, given the mass of patent families in play and given the difficulty of the exercise ([122]). PA Consulting reviewed only essentiality and not validity ([118]).

Patent 78
article thumbnail

SpicyIP Weekly Review (February 05- February 11)

SpicyIP

Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.

Trademark 103
article thumbnail

AIPPI Congress (Report 1): Is IP the "bogeyman" in access to Covid-19 vaccines?

The IPKat

This is the first in-person Congress since London hosted in 2019, so it was only apt that the first panel session was on the topic of IP and Covid-19. The study found that patenting was the most important for the mRNA platform, but most of the patents for the mRNA vaccines were filed a significant number of years before Covid in around 2013.

article thumbnail

SpicyIP Weekly Review (December 18- December 24)

SpicyIP

From an in-depth discussion on the terms of copyright and translations in India to the recent UK Supreme Court’s order regarding the patentability of inventions by an AI, we had some engaging posts on this blog this week. vs The Controller of Patents & Anr. Koninklijke Philips N.V. vs Oplus Mobitech India Pvt.